相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1-CD44 axis
Parimala Sonika Godavarthy et al.
HAEMATOLOGICA (2020)
Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth
Claudio Festuccia et al.
CELLS (2020)
A new way to treat proximal deep venous thrombosis using E-selectin inhibition
Daniel Myers et al.
JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2020)
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance
Valerie Barbier et al.
NATURE COMMUNICATIONS (2020)
Functional Blockade of E-Selectin in Tumor-Associated Vessels Enhances Anti-Tumor Effect of Doxorubicin in Breast Cancer
Yoshihiro Morita et al.
CANCERS (2020)
Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma
Cinzia Federico et al.
NATURE COMMUNICATIONS (2020)
Use of GMI-1271, an E-selectin antagonist, in healthy subjects and in 2 patients with calf vein thrombosis
Sumana Devata et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
L-Selectin Expression is Influenced by Phosphatase Activity in Chronic Lymphocytic LeukemiaKey terms
Ildiko Beke Debreceni et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2019)
Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis
Mark Esposito et al.
NATURE CELL BIOLOGY (2019)
Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy
Barbara Muz et al.
BLOOD CANCER JOURNAL (2019)
Ligation of the CD44 Glycoform HCELL on Culture-Expanded Human Monocyte-Derived Dendritic Cells Programs Transendothelial Migration
Paula A. Videira et al.
JOURNAL OF IMMUNOLOGY (2018)
P- and E-selectin receptor antagonism prevents human leukocyte adhesion to activated porcine endothelial monolayers and attenuates porcine endothelial damage
Christopher T. Laird et al.
XENOTRANSPLANTATION (2018)
Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B-cell lymphoma
Xiao-bo Ma et al.
CANCER MEDICINE (2018)
Mobilization of tumor-primed, marrow-infiltrating lymphocytes into peripheral blood with inhibitors of E-selectin or E-selectin and CXCR4
William E. Fogler et al.
CANCER RESEARCH (2018)
Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy
Buqing Sai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
E-Selectin Ligand Expression By Leukemic Blasts Is Associated with Prognosis in Patients with AML
Sylvia S. Chien et al.
BLOOD (2018)
Expression of CD43 in chronic lymphoproliferative leukemias
Marc Sorigue et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2018)
E-selectin-mediated rolling facilitates pancreatic cancer cell adhesion to hyaluronic acid
Daniel J. Shea et al.
FASEB JOURNAL (2017)
E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271
A. Natoni et al.
LEUKEMIA (2017)
GMI-1271, a novel E-selectin antagonist, combined with induction chemotherapy in elderly patients with untreated AML.
Daniel J. DeAngelo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins
M. Martinez-Moreno et al.
LEUKEMIA (2016)
Targeting cell adhesion and homing as strategy to cure Waldenstrom's macroglobulinemia
Steven T. Pals et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2016)
The effect of soluble E-selectin on tumor progression and metastasis
Shin-Ae Kang et al.
BMC CANCER (2016)
Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone
Trevor T. Price et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Dual E-Selectin/CXCR4 Antagonist GMI-1359 Exerts Efficient Anti-Leukemia Effects in a FLT3 ITD Mutated Acute Myeloid Leukemia Patient-Derived Xenograft Murine Model
Weiguo Zhang et al.
BLOOD (2016)
Administration of the Dual E-Selectin/CXCR4 Antagonist, GMI-1359, Results in a Unique Profile of Tumor Mobilization from the Bone Marrow and Facilitation of Chemotherapy in a Murine Model of FLT3 ITD AML
William E. Fogler et al.
BLOOD (2016)
E-Selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers
Dana E. Angelini et al.
BLOOD (2016)
CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation
Aldo M. Roccaro et al.
CELL REPORTS (2015)
Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib
Barbara Muz et al.
BIOMED RESEARCH INTERNATIONAL (2015)
First in Human Phase 1 Single Dose Escalation Studies of the E-Selectin Antagonist GMI-1271 Show a Favorable Safety, Pharmacokinetic, and Biomarker Profile
Sumana Devata et al.
BLOOD (2015)
Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche
Daniela S. Krause et al.
BLOOD (2014)
A small molecule glycomimetic antagonist of E-selectin (GMI-1271) prevents pancreatic tumor metastasis and offers a novel treatment for improved efficacy of chemotherapy
Maria M. Steele et al.
CANCER RESEARCH (2014)
Adhesion to fibronectin induces p27Kip1 nuclear accumulation through down-regulation of Jab1 and contributes to cell adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells
Min Fei et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
The Role of Hypoxia and Exploitation of the Hypoxic Environment in Hematologic Malignancies
Barbara Muz et al.
MOLECULAR CANCER RESEARCH (2014)
Hypoxia promotes stem cell-like phenotype in multiple myeloma cells
B. Muz et al.
BLOOD CANCER JOURNAL (2014)
E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis
Sayeda Yasmin-Karim et al.
ONCOTARGET (2014)
Vascular Niche E-Selectin Protects Acute Myeloid Leukaemia Stem Cells from Chemotherapy
Ingrid G. Winkler et al.
BLOOD (2014)
Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer
Elena Garcia-Martinez et al.
BREAST CANCER RESEARCH (2014)
Anoikis molecular pathways and its role in cancer progression
Paolo Paoli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target
Qiangwei Fu et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The influence of hypoxia on CML trafficking through modulation of CXCR4 and E-cadherin expression
A. K. Azab et al.
LEUKEMIA (2013)
P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment
Abdel Kareem Azab et al.
BLOOD (2012)
Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
Abdel Kareem Azab et al.
BLOOD (2012)
Bone Marrow Microenvironment in Multiple Myeloma Progression
S. Manier et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
E-selectin as a target for drug delivery and molecular imaging
Emile Jubeli et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance
Ingrid G. Winkler et al.
NATURE MEDICINE (2012)
A Novel Small Molecule E-Selectin Inhibitor GMI-1271 Blocks Adhesion of AML Blasts to E-Selectin and Mobilizes Blood Cells in Nodscid IL2Rgc-/- Mice Engrafted with Human AML
Sylvia Chien et al.
BLOOD (2012)
Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3
Nicolas Porquet et al.
BMC CANCER (2011)
Selectins as Mediators of Lung Metastasis
Heinz Laubli et al.
CANCER MICROENVIRONMENT (2010)
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma
Abdel Kareem Azab et al.
BLOOD (2009)
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy
Abdel Kareem Azab et al.
BLOOD (2009)
Environment-mediated drug resistance: a major contributor to minimal residual disease
Mark B. Meads et al.
NATURE REVIEWS CANCER (2009)
CD43, but not P-selectin glycoprotein ligand-1, functions as an E-selectin counter-receptor in human pre-B-cell leukemia NALL-1
Chizu Nonomura et al.
CANCER RESEARCH (2008)
Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells
Daniela S. Krause et al.
NATURE MEDICINE (2006)
Death receptor-3, a new E-selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation
Stephanie Gout et al.
CANCER RESEARCH (2006)
CD43 functions as a ligand for E-selectin on activated T cells
M Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2005)
Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells
CJ Dimitroff et al.
CANCER RESEARCH (2005)
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
DA Sipkins et al.
NATURE (2005)
Selectins facilitate carcinoma metastasis and heparin can prevent them
L Borsig
NEWS IN PHYSIOLOGICAL SCIENCES (2004)
Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin
CJ Dimitroff et al.
CANCER RESEARCH (2004)
分享论文
